SCHEMBL7673620

SCHEMBL7673620

COc1ccc(C=CC(=O)O)c(CC(O)CN2CCOCC2)c1OC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.47
KDM4E B2RXH2 5/20 0.47
HPGD P15428 4/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
CYP2D6 P10635 1/20 0.47
TSHR P16473 2/20 0.43
HTT P42858 2/20 0.43
MAPT P10636 4/20 0.43
LMNA P02545 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
GAA P10253 1/20 0.43
NPC1 O15118 1/20 0.42
TP53 P04637 1/20 0.41
MAPK1 P28482 1/20 0.41
PAX8 Q06710 1/20 0.41
ABCB1 P08183 2/20 0.40
LDHA P00338 1/20 0.40
RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7673613 1.00 ALDH1A1 (0.47) ALDH1A1KDM4EHPGDL3MBTL1CYP2D6
SCHEMBL6550497 0.90 POLB (0.45) ALDH1A1KDM4EHPGDL3MBTL1TSHR
SCHEMBL6550490 0.90 POLB (0.45) ALDH1A1KDM4EHPGDL3MBTL1TSHR
Hydrochloric Acid SCHEMBL6548749 0.85 TSHR (0.46) ALDH1A1KDM4EHPGDL3MBTL1CYP2D6
Hydrochloric Acid SCHEMBL6548051 0.85 TSHR (0.46) ALDH1A1KDM4EHPGDL3MBTL1CYP2D6
SCHEMBL7683845 0.82 MEN1 (0.49) ALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL7683841 0.82 MEN1 (0.49) ALDH1A1L3MBTL1MEN1KMT2A
Hydrochloric Acid SCHEMBL6548838 0.77 MAPT (0.40) ALDH1A1KDM4EHPGDL3MBTL1CYP2D6
SCHEMBL6550737 0.75 NFE2L2 (0.40) ALDH1A1KDM4EHPGDCYP2D6LMNA
SCHEMBL6550733 0.75 NFE2L2 (0.40) ALDH1A1KDM4EHPGDCYP2D6LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6500823-B1 ENERGY DEFICIENCY OF THE CELL CAUSED BY PARP INHIBITION, IN DIABETES COMPLICATIONS, IN OXYGEN DEFICIENT STATUS OF THE HEART AND BRAIN, IN NEURODEGENERATIVE DISEASES, IN THE TREATMENT OF AUTOIMMUNE AND/OR VIRAL DISEASES N-GENE RESEARCH LABORATORIES, INC. 2002-12-31 US claimed